HQL (HQL) Stock Price & Analysis
HQL (HQL) rose 0.66% to USD 16.78 as of June 10, 2026 at 00:46 UTC, according to Nexqual real-time market data.
HQL last closed at USD 16.67; the session ranged USD 16.34–16.95 on volume of 163,948 shares. Market capitalization is $510.25M, with a 52-week range of USD 12.34–18.46 (NYQ). Source: Nexqual, June 10, 2026 at 00:46 UTC.
Key Statistics (as of June 10, 2026 at 00:46 UTC)
| Price | USD 16.78 |
|---|---|
| Change | ▲ 0.66% (up) |
| Previous Close | USD 16.67 |
| Open | USD 16.82 |
| Day Range | USD 16.34 – 16.95 |
| 52-Week Range | USD 12.34 – 18.46 |
| Volume | 163,948 shares |
| Market Cap | $510.25M |
| Exchange | NYQ |
Technical Analysis (HQL)
Nexqual's technical model rates HQL "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:46 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 39.17 (neutral) |
| vs SMA50 | Below (USD 17.47) |
| MACD | -0.19 (negative) |
Analyst Ratings (HQL)
Wall Street analysts rate HQL "None", per Nexqual as of June 10, 2026 at 00:46 UTC.
| Consensus Rating | None |
|---|
Earnings (HQL)
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Financials & Fundamentals (HQL)
| Total Revenue | $1.11M |
|---|---|
| Revenue Growth (YoY) | -60.80% |
| Gross Margin | +100.00% |
| Operating Margin | -516.53% |
| Profit Margin | +17856.98% |
| ROE | +41.42% |
| Current Ratio | 2.65 |
| Total Cash | $851,602 |
| Total Debt | $0 |
| Free Cash Flow | $-4.35M |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Financial Health Score (HQL)
Nexqual rates HQL's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:46 UTC.
| Growth | Critical — Revenue -61% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $852K cash, no debt |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Strong — ROE 41%, ROA -0.6% |
Ownership (HQL)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +27.76% |
| Shares Outstanding | 30.41M |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Leadership (HQL)
HQL is led by Daniel R. Omstead M.S (age 72), Principal Executive Officer, President and Trustee, per Nexqual as of June 10, 2026 at 00:46 UTC.
| Principal Executive Officer, President and Trustee | Daniel R. Omstead M.S (age 72) |
|---|
Major Backers & Investors (HQL)
Notable institutional backers of HQL include Morgan Stanley, Saba Capital Management, L.P., Penserra Capital Management LLC, according to Nexqual as of June 10, 2026 at 00:46 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 5.17% |
| Saba Capital Management, L.P. | 3.4% |
| Penserra Capital Management LLC | 2.65% |
| Amplify ETF Trust-Amplify CEF High Income ETF | 2.64% |
| Raymond James Financial, Inc. | 2.17% |
| LPL Financial LLC | 1.57% |
| Needham Investment Management, L.L.C. | 1.41% |
| Flagship Harbor Advisors, LLC | 1.26% |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HQH | Tekla Healthcare Investors | USD 18.9 | ▼ 1.15% |
| RVT | Royce Value Trust, Inc. | USD 17.75 | ▲ 0.68% |
| THQ | Tekla Healthcare Opportunies Fu | USD 18.57 | ▲ 1.75% |
| THW | Tekla World Healthcare Fund Sha | USD 12.17 | ▼ 2.17% |
| BTO | John Hancock Financial Opportun | USD 37.77 | ▲ 2.05% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:46 UTC. This page is informational and not investment advice.